Testing, Inspection Deviations Land French Sanofi Pasteur Plant Form 483

Drug GMP Report
A A
One of Sanofi Pasteur’s French manufacturing facilities received an FDA Form 483 for straying from agency regulations on investigating discrepancies and testing samples of supplied materials.

To View This Article:

Login

Subscribe To Drug GMP Report

Buy This Article Now

Add this article to your cart for $135.00